Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
84
NMPA:84
Drug Approvals
Sulfadiazine Sodium Injection
- Product Name
- 磺胺嘧啶钠注射液
- Approval Number
- 国药准字H41023475
- Approval Date
- Mar 5, 2024
NMPA
Raceanisodamine Hydrochloride Injection
- Product Name
- 盐酸消旋山茛菪碱注射液
- Approval Number
- 国药准字H41023062
- Approval Date
- Mar 5, 2024
NMPA
Chlorphenamine Maleate Injection
- Product Name
- 马来酸氯苯那敏注射液
- Approval Number
- 国药准字H20045161
- Approval Date
- Mar 5, 2024
NMPA
Calcium Gluconate Injection
- Product Name
- 葡萄糖酸钙注射液
- Approval Number
- 国药准字H41023479
- Approval Date
- Mar 5, 2024
NMPA
Hydroxocobalamine Hydrochloride Injection
- Product Name
- 盐酸羟钴胺注射液
- Approval Number
- 国药准字H41024838
- Approval Date
- Mar 5, 2024
NMPA
Raceanisodamine Hydrochloride Injection
- Product Name
- 盐酸消旋山茛菪碱注射液
- Approval Number
- 国药准字H41023061
- Approval Date
- Mar 5, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
No trials found
News
No news found